BBVA
EW icon

Banco Bilbao Vizcaya Argentaria’s Edwards Lifesciences EW Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.98M Sell
88,413
-21
-0% -$1.76K 0.05% 238
2026
Q1 		$7.05M Sell
88,434
-145,591
-62% -$12M 0.05% 238
2025
Q4 		$20M Buy
234,025
+15,276
+7% +$1.25M 0.14% 123
2025
Q3 		$17M Buy
218,749
+18,498
+9% +$1.45M 0.13% 135
2025
Q2 		$15.7M Buy
200,251
+17,982
+10% +$1.34M 0.14% 134
2025
Q1 		$13.2M Buy
182,269
+32,673
+22% +$2.34M 0.13% 146
2024
Q4 		$11.1M Buy
149,596
+17,726
+13% +$1.24M 0.12% 160
2024
Q3 		$8.7M Buy
131,870
+6,738
+5% +$490K 0.09% 199
2024
Q2 		$11.6M Sell
125,132
-724
-0.6% -$64.1K 0.12% 162
2024
Q1 		$12M Sell
125,856
-19,569
-13% -$1.64M 0.14% 159
2023
Q4 		$11.1M Sell
145,425
-353
-0.2% -$24.6K 0.13% 168
2023
Q3 		$10.1M Buy
145,778
+9,694
+7% +$779K 0.14% 167
2023
Q2 		$12.8M Sell
136,084
-1,385
-1% -$120K 0.17% 139
2023
Q1 		$11.4M Sell
137,469
-9,564
-7% -$752K 0.14% 164
2022
Q4 		$11M Buy
147,033
+21,702
+17% +$1.67M 0.16% 149
2022
Q3 		$10.4M Buy
125,331
+1,444
+1% +$139K 0.17% 120
2022
Q2 		$11.8M Buy
123,887
+1,300
+1% +$135K 0.18% 121
2022
Q1 		$14.9M Sell
122,587
-10,696
-8% -$1.2M 0.2% 107
2021
Q4 		$17.4M Buy
133,283
+105,790
+385% +$12.3M 0.23% 88
2021
Q3 		$3.12M Buy
27,493
+2,213
+9% +$253K 0.05% 294
2021
Q2 		$2.62M Sell
25,280
-3,307
-12% -$312K 0.05% 319
2021
Q1 		$2.39M Sell
28,587
-995
-3% -$84.1K 0.05% 311
2020
Q4 		$2.7M Sell
29,582
-2,220
-7% -$184K 0.06% 277
2020
Q3 		$2.54M Buy
31,802
+2,516
+9% +$196K 0.07% 232
2020
Q2 		$2.02M Sell
29,286
-45,006
-61% -$3.2M 0.07% 238
2020
Q1 		$4.67M Buy
74,292
+21,357
+40% +$1.54M 0.17% 125
2019
Q4 		$4.12M Buy
+52,935
New +$4.13M 0.13% 180

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's EW Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Edwards Lifesciences (EW) stake by 0.02% in Q2 2026, selling an estimated $1.76K and leaving 88,413 shares worth $7.98M. The position accounts for 0.05% of the portfolio, ranked #238.

Banco Bilbao Vizcaya Argentaria first reported a position in EW in Q4 2019 and has held it in 27 quarters since. The position peaked at $20M in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Banco Bilbao Vizcaya Argentaria held 88,413 shares of Edwards Lifesciences worth $7.98M as of Q2 2026.
  • Banco Bilbao Vizcaya Argentaria sold 21 Edwards Lifesciences shares in Q2 2026, an estimated $1.76K.
  • Edwards Lifesciences made up 0.05% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #238 holding.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 27 quarters since.
  • Banco Bilbao Vizcaya Argentaria's Edwards Lifesciences position peaked at $20M in Q4 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.